Clinical Trial Update: A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A prospective Phase 2 interventional trial evaluating response to the ADE regimen (cytarabine, daunorubicin, and etoposide) for first relapse of pediatric acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Etoposide (Etoposide)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Acute Myeloid Leukemia, in Relapse | Phase 2 | Status: UNKNOWN